BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 10438841)

  • 21. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
    Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
    J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.
    Fernàndez G; Llano A; Esgleas M; Clotet B; Esté JA; Martínez MA
    J Gen Virol; 2006 May; 87(Pt 5):1285-1294. PubMed ID: 16603531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
    Derdeyn CA; Decker JM; Sfakianos JN; Wu X; O'Brien WA; Ratner L; Kappes JC; Shaw GM; Hunter E
    J Virol; 2000 Sep; 74(18):8358-67. PubMed ID: 10954535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC; Margolis LB
    Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions.
    Suzuki Y; Koyanagi Y; Tanaka Y; Murakami T; Misawa N; Maeda N; Kimura T; Shida H; Hoxie JA; O'Brien WA; Yamamoto N
    J Virol; 1999 Jan; 73(1):316-24. PubMed ID: 9847335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.
    Penn ML; Grivel JC; Schramm B; Goldsmith MA; Margolis L
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):663-8. PubMed ID: 9892690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased in vitro replication of CC chemokine receptor 5-restricted human immunodeficiency virus type 1 primary isolates in Th2 lymphocytes may correlate with AIDS progression.
    Ofori H; Jagodziński PP
    Scand J Infect Dis; 2004; 36(1):46-51. PubMed ID: 15000559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-4 and a glucocorticoid up-regulate CXCR4 expression on human CD4+ T lymphocytes and enhance HIV-1 replication.
    Wang J; Harada A; Matsushita S; Matsumi S; Zhang Y; Shioda T; Nagai Y; Matsushima K
    J Leukoc Biol; 1998 Nov; 64(5):642-9. PubMed ID: 9823770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus.
    Aiuti A; Turchetto L; Cota M; Cipponi A; Brambilla A; Arcelloni C; Paroni R; Vicenzi E; Bordignon C; Poli G
    Blood; 1999 Jul; 94(1):62-73. PubMed ID: 10381499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.
    Sironi F; Malnati M; Mongelli N; Cozzi P; Guzzo C; Ghezzi S; Martínez-Romero C; García-Sastre A; Lusso P; Jabes D; Biswas P
    J Transl Med; 2015 Apr; 13():107. PubMed ID: 25888743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
    Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
    J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones.
    Ariën KK; Gali Y; El-Abdellati A; Heyndrickx L; Janssens W; Vanham G
    Virology; 2006 Mar; 347(1):65-74. PubMed ID: 16386774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The density of coreceptors at the surface of CD4+ T cells contributes to the extent of human immunodeficiency virus type 1 viral replication-mediated T cell death.
    Lelièvre JD; Petit F; Perrin L; Mammano F; Arnoult D; Ameisen JC; Corbeil J; Gervaix A; Estaquier J
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1230-43. PubMed ID: 15588345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.
    Aiamkitsumrit B; Dampier W; Martin-Garcia J; Nonnemacher MR; Pirrone V; Ivanova T; Zhong W; Kilareski E; Aldigun H; Frantz B; Rimbey M; Wojno A; Passic S; Williams JW; Shah S; Blakey B; Parikh N; Jacobson JM; Moldover B; Wigdahl B
    PLoS One; 2014; 9(9):e107389. PubMed ID: 25265194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
    Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
    J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.